Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

During the past decade, Parkinson disease (PD) has evolved from a textbook example of a mostly nonhereditary disease to a complex disorder with a well-established genetic component in a ...

Yulan Xiong, associate professor of neuroscience at UConn Health, and her team have discovered one more piece of the puzzle ...

A novel wireless photothermal DBS nanosystem uses nanoparticles to target and restore damaged neurons in Parkinson’s disease, ...

At the same time, the German group's Asklepios BioPharma (AskBio) unit has started recruiting patients for a phase 1b trial of its gene therapy for Parkinson's, another treatment with the ...

Genetic Variations May Predispose People to Parkinson's Disease Following Long-Term Pesticide Exposure, Study Finds Apr. 25, 2024 — A new study found certain genetic variants could help explain ...

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...